Cargando…

Association Between Plasma Lipoprotein-Associated Phospholipase A2 and Plaque Vulnerability in TIA Patients With Unilateral Middle Cerebral Artery Stenosis

Background: Plasma lipoprotein-associated phospholipase A2 (Lp-PLA2) has emerged as a novel biomarker for coronary atherosclerosis. However, the association between Lp-PLA2 and plaque vulnerability in atherosclerosis of cervicocerebral arteries remains poorly defined, especially for intracranial ath...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qin, Yiren, Qian, Xiaoyan, Luo, Xue, Li, Yuanfang, Wang, Dapeng, Jiang, Jianhua, Zhang, Quanquan, Liu, Meirong, Xiao, Junhua, Zhang, Yan, Diao, Shanshan, Zhao, Hongru
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7596647/ https://www.ncbi.nlm.nih.gov/pubmed/33178116 http://dx.doi.org/10.3389/fneur.2020.574036

Ejemplares similares

Association of Lipoprotein-Associated Phospholipase A(2) with Characteristics of Vulnerable Coronary Atherosclerotic Plaques
por: Liu, Yu-Sheng, et al.
Publicado: (2011)

DNA methylome profiling reveals epigenetic regulation of lipoprotein-associated phospholipase A(2) in human vulnerable atherosclerotic plaque
por: Li, Jingjin, et al.
Publicado: (2021)

Lipoprotein‐associated phospholipase A2: The story continues
por: Huang, Fubao, et al.
Publicado: (2019)

Adequate Platelet Function Inhibition Confirmed by Two Inductive Agents Predicts Lower Recurrence of Ischemic Stroke/Transient Ischemic Attack
por: Zhang, Lulu, et al.
Publicado: (2017)

Lipoprotein-Associated Phospholipase A(2) Is Related to Plaque Stability and Is a Potential Biomarker for Acute Coronary Syndrome
por: Chung, Hyemoon, et al.
Publicado: (2014)

Association of lipoprotein‐associated phospholipase A2 mass with asymptomatic cerebral artery stenosis
por: Wang, Youxin, et al.
Publicado: (2018)

Atherosclerotic Plaque Inflammation Varies Between Vascular Sites and Correlates With Response to Inhibition of Lipoprotein‐Associated Phospholipase A(2)
por: Fenning, Robert S., et al.
Publicado: (2015)

Low-density lipoprotein, its susceptibility to oxidation and the role of lipoprotein-associated phospholipase A(2) and carboxyl ester lipase lipases in atherosclerotic plaque formation
por: Burchardt, Paweł, et al.
Publicado: (2013)

Lipoprotein-associated phospholipase A2 and oxidized low-density lipoprotein in young patients with acute coronary syndrome in China
por: Huang, Yuli, et al.
Publicado: (2017)

Inhibition of Lipoprotein-Associated Phospholipase A2 Ameliorates Inflammation and Decreases Atherosclerotic Plaque Formation in ApoE-Deficient Mice
por: Wang, Wen-yi, et al.
Publicado: (2011)

Effect of Darapladib Treatment on Endarterectomy Carotid Plaque Lipoprotein-Associated Phospholipase A(2) Activity: A Randomized, Controlled Trial
por: Johnson, Joel L., et al.
Publicado: (2014)

Elevated Lipoprotein-Associated Phospholipase A2 Is Associated With Intracranial Atherosclerosis
por: Wang, Yuan, et al.
Publicado: (2022)

Lipoprotein-associated phospholipase A2, homocysteine, and Alzheimer's disease
por: Doody, Rachelle S., et al.
Publicado: (2015)

Lipoprotein (a) level is associated with plaque vulnerability in patients with coronary artery disease: An optical coherence tomography study
por: Muramatsu, Yusuke, et al.
Publicado: (2019)

Interleukin-6 and lipoprotein-associated phospholipase A2 are associated with functional trajectories
por: Dhamoon, Mandip S., et al.
Publicado: (2019)

Association of Lipoprotein(a) With Atherosclerotic Plaque Progression
por: Kaiser, Yannick, et al.
Publicado: (2022)

Racial variation in lipoprotein-associated phospholipase A(2 )in older adults
por: Lee, Keane K, et al.
Publicado: (2011)

Elevated lipoprotein(a) and lipoprotein-associated phospholipase A(2) are associated with unfavorable functional outcomes in patients with ischemic stroke
por: Jiang, Xue, et al.
Publicado: (2021)

Lipoprotein (a) levels and vulnerable characteristics in nonculprit plaque in patients with acute coronary syndrome()
por: Kato, Ayami, et al.
Publicado: (2022)

Low Density Lipoprotein-Cholesterol/High Density Lipoprotein-Cholesterol Ratio Predicts Plaque Vulnerability in Patients With Stable Angina
por: Kim, Jeong Hun, et al.
Publicado: (2012)

The Association of Plasma Apelin Levels with Plaque Vulnerability
por: Keskin, Kudret, et al.
Publicado: (2019)

Lipoprotein-Associated Phospholipase A(2), Vascular Inflammation and Cardiovascular Risk Prediction
por: Sudhir, Krishnankutty
Publicado: (2006)

Is lipoprotein-associated phospholipase A(2) correlated with cardiovascular risk in European women?
por: Hirschler, V.
Publicado: (2013)

The correlation between lipoprotein associated phospholipase A(2) and central overweight status
por: Chen, Yi-Hsuan, et al.
Publicado: (2021)

Lipoprotein-associated phospholipase A(2): A paradigm for allosteric regulation by membranes
por: Mouchlis, Varnavas D., et al.
Publicado: (2022)

Lipoprotein-Associated Phospholipase A2 Activity as Potential Biomarker of Vascular Dementia
por: Zuliani, Giovanni, et al.
Publicado: (2023)

The diagnostic value of lipoprotein-associated phospholipase A2 in early diabetic nephropathy
por: Zhai, Yan, et al.
Publicado: (2023)

Association of Lipoprotein-associated Phospholipase A2 with Coronary Calcification among American and Japanese Men
por: El-Saed, Aiman, et al.
Publicado: (2007)

Lipoprotein-Associated Phospholipase A2 Is Associated with Atherosclerotic Stroke Risk: The Northern Manhattan Study
por: Katan, Mira, et al.
Publicado: (2014)

Increased plasma lipoprotein-associated phospholipase A2 levels are associated with coronary slow flow
por: Ding, Yao-dong, et al.
Publicado: (2020)

BIRC6 Is Associated with Vulnerability of Carotid Atherosclerotic Plaque
por: Alloza, Iraide, et al.
Publicado: (2020)

Association of Carotid Plaque and Serum Lipoprotein-Associated Phospholipase A2 (LP-PLA2) with Postoperative Delirium in Geriatric Patients Undergoing Hip Replacement: A Prospective Cohort Study
por: Wan, Tiantian, et al.
Publicado: (2020)

Plasma Lipoprotein-associated Phospholipase A2 in Patients with Metabolic Syndrome and Carotid Atherosclerosis
por: Gong, Hui-ping, et al.
Publicado: (2011)

Ambient Air Pollution and Lipoprotein-Associated Phospholipase A(2) in Survivors of Myocardial Infarction
por: Brüske, Irene, et al.
Publicado: (2011)

Evaluation of lipoprotein-associated Phospholipase A2 in Healthy Chinese Han Adult Serum
por: Feng, Li-Min, et al.
Publicado: (2014)

Correlation between plasma lipoprotein-associated phospholipase A(2) and peripheral arterial disease
por: LI, SHUAI-BING, et al.
Publicado: (2013)

The Role of Lipoprotein-Associated Phospholipase A₂ in a Murine Model of Experimental Autoimmune Uveoretinitis
por: Crawford, G. L., et al.
Publicado: (2015)

The relationship of lipoprotein-associated phospholipase A2 activity with the seriousness of coronary artery disease
por: Zhang, Hao, et al.
Publicado: (2020)

The role of lipoprotein-associated phospholipase A2 in acute kidney injury of septic mice
por: Liang, Guiwen, et al.
Publicado: (2020)

Lipoprotein-Associated Phospholipase A2 Is a Risk Factor for Patients With Parkinson’s Disease
por: Wu, Zubo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ohg2u6v4sgutrsa9vafg1me9se